Cargando…

A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis

BACKGROUND: Pyrazinamide (PZA) is crucial for tuberculosis (TB) treatment, given its unique ability to eradicate persister bacilli. The worldwide burden of PZA resistance remains poorly described. METHODS: Systematic PubMed, Science Direct and Scopus searches for articles reporting phenotypic (liqui...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whitfield, Michael G., Soeters, Heidi M., Warren, Robin M., York, Talita, Sampson, Samantha L., Streicher, Elizabeth M., van Helden, Paul D., van Rie, Annelies
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517823/ https://www.ncbi.nlm.nih.gov/pubmed/26218737 http://dx.doi.org/10.1371/journal.pone.0133869

Ejemplares similares

Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosis
por: Whitfield, Michael G., et al.
Publicado: (2022)

Rapid Pyrazinamide Drug Susceptibility Testing using a Closed-Tube PCR Assay of the Entire pncA gene
por: Whitfield, Michael G., et al.
Publicado: (2020)

The Effect of Tuberculosis Treatment at Combination Antiretroviral Therapy Initiation on Subsequent Mortality: A Systematic Review and Meta-Analysis
por: Soeters, Heidi M., et al.
Publicado: (2013)

The pyrazinamide susceptibility breakpoint above which combination therapy fails
por: Gumbo, Tawanda, et al.
Publicado: (2014)

Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates
por: Huy, Nguyen Quang, et al.
Publicado: (2017)

Site-directed mutagenesis of Mycobacterium tuberculosis and functional validation to investigate potential bedaquiline resistance-causing mutations
por: Otum, Christian C., et al.
Publicado: (2023)

Pyrazinamide resistance in rifampicin discordant tuberculosis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2022)

Pyrazinamide induced thrombocytopenia
por: Kant, Surya, et al.
Publicado: (2010)

Molecular epidemiology of drug resistant Mycobacterium tuberculosis in Africa: a systematic review
por: Chisompola, Namaunga Kasumu, et al.
Publicado: (2020)

Performance of Wayne assay for detection of pyrazinamide resistance in Mycobacterium tuberculosis: a meta-analysis study
por: Nasiri, M.J., et al.
Publicado: (2021)

PYRAZINAMIDE-INDUCED MACULOPAPULAR RASH
por: Khayyam, Khalid Umer, et al.
Publicado: (2010)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
por: Somoskovi, Akos, et al.
Publicado: (2001)

Impact of immunopathology on the antituberculous activity of pyrazinamide
por: Blanc, Landry, et al.
Publicado: (2018)

Structure guided prediction of Pyrazinamide resistance mutations in pncA
por: Karmakar, Malancha, et al.
Publicado: (2020)

Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania
por: Juma, Saumu Pazia, et al.
Publicado: (2019)

Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment()
por: Driesen, M., et al.
Publicado: (2018)

Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study
por: Miotto, Paolo, et al.
Publicado: (2014)

Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions
por: Gey van Pittius, Nicolaas C, et al.
Publicado: (2006)

Optimization of SABRE for polarization of the tuberculosis drugs pyrazinamide and isoniazid
por: Zeng, Haifeng, et al.
Publicado: (2013)

Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia
por: Sengstake, Sarah, et al.
Publicado: (2017)

Pyrazinamide may possess cardioprotective properties
por: Sinha, Sharabh, et al.
Publicado: (2019)

Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosis
por: Werngren, Jim, et al.
Publicado: (2021)

Dynamics and disorder: on the stability of pyrazinamide polymorphs
por: Hoser, Anna Agnieszka, et al.
Publicado: (2022)

Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
por: Lee, K. W., et al.
Publicado: (2001)

The plasmid-mediated evolution of the mycobacterial ESX (Type VII) secretion systems
por: Newton-Foot, Mae, et al.
Publicado: (2016)

Genetic diversity of Mycobacterium tuberculosis complex strains isolated from livestock workers and cattle in Nigeria
por: Adesokan, Hezekiah K., et al.
Publicado: (2019)

Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular Diagnostics
por: Modlin, Samuel J., et al.
Publicado: (2023)

Enhancement of cyclophosphamide cytotoxicity in vivo by the benzamide analogue pyrazinamide.
por: Horsman, M. R., et al.
Publicado: (1994)

Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa
por: Oostvogels, Selien, et al.
Publicado: (2022)

High Frequency of Resistance, Lack of Clinical Benefit, and Poor Outcomes in Capreomycin Treated South African Patients with Extensively Drug-Resistant Tuberculosis
por: Pietersen, Elize, et al.
Publicado: (2015)

Antimicrobial Activity of Pyrazinamide Coordination Frameworks Synthesized by Mechanochemistry
por: Quaresma, Sílvia, et al.
Publicado: (2021)

Insight to pyrazinamide resistance inMycobacterium tuberculosisby molecular docking
por: Unissa, Amirudeen Nusrath, et al.
Publicado: (2009)

Pyrazinamide resistance of novel mutations in pncA and their dynamic behavior
por: Ali, Arif, et al.
Publicado: (2020)

Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis
por: Modlin, Samuel J., et al.
Publicado: (2021)

The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates
por: Tomasicchio, Michele, et al.
Publicado: (2016)

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China
por: Xia, Hui, et al.
Publicado: (2020)

Modification of tumour radiation response in vivo by the benzamide analogue pyrazinamide.
por: Chaplin, D. J., et al.
Publicado: (1990)

A case of thrombocytopenia caused by rifampicin and pyrazinamide
por: Bansal, Rekha, et al.
Publicado: (2013)

Revisiting Anti-tuberculosis Activity of Pyrazinamide in Mice
por: Almeida, Deepak V., et al.
Publicado: (2014)

Serum pyrazinamide concentrations in patients with pulmonary tuberculosis
por: Lucena, Stefania de Medeiros Araujo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uq72t22mlbvv0vedg9iplhboga